Stratton John G
SEC CIK 1385262 · EDGAR
BoughtSold
Most active insiders at GD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | NOVAKOVIC PHEBE N | COB, CEO, Dir | — | $31.38M |
| 2 | Burns Mark Lagrand | EVP | — | $28.64M |
| 3 | Gilliland Marguerite Amy | EVP | — | $17.67M |
| 4 | Paddock David | VP | — | $6.82M |
| 5 | Brady Christopher J | VP | — | $2.42M |
| 6 | Malcolm Mark | Dir | — | $2.00M |
| 7 | Rayha Mark | VP | — | $1.56M |
| 8 | Gallopoulos Gregory S | Senior VP, Gen. Counsel, Sec | — | $1.32M |
| 9 | Wall Peter A | Dir | — | $788.9K |
| 10 | Maisano Dana Omahen | VP | — | — |
| 21 | Stratton John G | Dir | — | — |
Transactions 36
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-18 13:41 | 2026-09-16 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $356.69 | +105 | 8,589 | +1% | +$37.5K | |
| 2026-06-18 17:08 | 2026-05-07 | ABT | Abbott Laboratories | Stratton John G | Dir | P - Purchase | $86.82 | +2,000 | 23.3K | +9% | +$173.6K | |
| 2026-06-18 16:22 | 2026-06-16 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $359.85 | +104 | 8,484 | +1% | +$37.4K | |
| 2026-04-28 19:45 | 2026-04-24 | ABT | Abbott Laboratories | Stratton John G | Dir | A - Grant | $0.00 | +2,286 | 21.3K | +12% | $0 | |
| 2026-03-19 | 2026-03-17 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $354.31 | +105 | 8,380 | +1% | +$37.2K | |
| 2026-03-11 | 2026-03-09 | GD | General Dynamics | Stratton John G | Dir | F - Tax | $359.79 | -83 | 8,275 | -1.0% | -$29.9K | |
| D | 2026-03-06 | 2026-03-04 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $0.00 | +270 | 8,358 | +3% | $0 |
| 2025-12-18 | 2025-12-16 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $339.14 | +92 | 8,088 | +1% | +$31.2K | |
| 2025-09-18 | 2025-09-16 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $326.97 | +95 | 7,996 | +1% | +$31.1K | |
| 2025-06-20 | 2025-06-17 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $281.11 | +111 | 7,901 | +1% | +$31.2K | |
| 2025-04-29 | 2025-04-25 | ABT | Abbott Laboratories | Stratton John G | Dir | A - Grant | $0.00 | +1,635 | 19.0K | +9% | $0 | |
| 2025-03-20 | 2025-03-18 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $264.50 | +118 | 7,790 | +2% | +$31.2K | |
| D | 2025-03-06 | 2025-03-05 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $0.00 | +330 | 7,672 | +4% | $0 |
| 2025-03-05 | 2025-03-03 | GD | General Dynamics | Stratton John G | Dir | F - Tax | $254.11 | -81 | 7,342 | -1% | -$20.6K | |
| 2024-12-19 | 2024-12-17 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $266.20 | +117 | 7,423 | +2% | +$31.1K | |
| 2024-09-19 | 2024-09-17 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $308.05 | +101 | 7,306 | +1% | +$31.1K | |
| 2024-06-21 | 2024-06-18 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $292.42 | +106 | 7,205 | +1% | +$31.0K | |
| 2024-04-30 | 2024-04-26 | ABT | Abbott Laboratories | Stratton John G | Dir | A - Grant | $0.00 | +1,866 | 17.4K | +12% | $0 | |
| 2024-03-20 | 2024-03-18 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $275.38 | +113 | 7,099 | +2% | +$31.1K | |
| D | 2024-03-07 | 2024-03-06 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $0.00 | +310 | 6,986 | +5% | $0 |
| 2024-03-06 | 2024-03-04 | GD | General Dynamics | Stratton John G | Dir | F - Tax | $273.37 | -105 | 6,676 | -2% | -$28.7K | |
| 2023-12-20 | 2023-12-18 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $251.04 | +124 | 6,781 | +2% | +$31.1K | |
| 2023-09-20 | 2023-09-18 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $222.80 | +140 | 6,657 | +2% | +$31.2K | |
| 2023-06-20 | 2023-06-16 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $213.80 | +146 | 6,517 | +2% | +$31.2K | |
| 2023-05-02 | 2023-04-28 | ABT | Abbott Laboratories | Stratton John G | Dir | A - Grant | $0.00 | +1,816 | 15.5K | +13% | $0 | |
| 2023-03-20 | 2023-03-16 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $215.31 | +145 | 6,371 | +2% | +$31.2K | |
| D | 2023-03-09 | 2023-03-08 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $0.00 | +375 | 6,226 | +6% | $0 |
| 2023-03-08 | 2023-03-06 | GD | General Dynamics | Stratton John G | Dir | F - Tax | $231.97 | -107 | 5,851 | -2% | -$24.8K | |
| 2022-12-20 | 2022-12-16 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $245.39 | +127 | 5,958 | +2% | +$31.2K | |
| 2022-09-20 | 2022-09-16 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $229.00 | +136 | 5,831 | +2% | +$31.1K | |
| 2022-06-21 | 2022-06-16 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $218.01 | +143 | 5,695 | +3% | +$31.2K | |
| 2022-05-03 | 2022-04-29 | ABT | Abbott Laboratories | Stratton John G | Dir | A - Grant | $0.00 | +1,602 | 13.7K | +13% | $0 | |
| 2022-03-17 | 2022-03-16 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $235.91 | +132 | 5,552 | +2% | +$31.1K | |
| D | 2022-03-04 | 2022-03-02 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $0.00 | +365 | 5,420 | +7% | $0 |
| 2021-12-20 | 2021-12-16 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $204.85 | +115 | 5,055 | +2% | +$23.6K | |
| 2021-09-20 | 2021-09-16 | GD | General Dynamics | Stratton John G | Dir | A - Grant | $197.77 | +120 | 4,940 | +2% | +$23.7K |
Purchase Sale Sale after option exercise All abbreviations